You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 8, 2024

Chartwell Rx Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for CHARTWELL RX, and what generic and branded alternatives to CHARTWELL RX drugs are available?

CHARTWELL RX has three hundred and eighty-two approved drugs.

There is one tentative approval on CHARTWELL RX drugs.

Summary for Chartwell Rx

US Patents:	0
Tradenames:	269
Ingredients:	256
NDAs:	382

Drugs and US Patents for Chartwell Rx

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chartwell Rx	HYDROXYZINE HYDROCHLORIDE	hydroxyzine hydrochloride	SYRUP;ORAL	087294-001	Apr 12, 1982	AA	RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Chartwell Rx	THIORIDAZINE HYDROCHLORIDE	thioridazine hydrochloride	TABLET;ORAL	088133-001	Aug 30, 1983		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Chartwell Rx	FOSINOPRIL SODIUM	fosinopril sodium	TABLET;ORAL	076483-001	Apr 23, 2004	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Chartwell Rx	BETHANECHOL CHLORIDE	bethanechol chloride	TABLET;ORAL	040728-002	Oct 26, 2007	AA	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Chartwell Rx	FLUVOXAMINE MALEATE	fluvoxamine maleate	TABLET;ORAL	075900-002	Feb 23, 2006		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Chartwell Rx	DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE	atropine sulfate; diphenoxylate hydrochloride	TABLET;ORAL	207128-001	Oct 21, 2020	AA	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Chartwell Rx	VERAPAMIL HYDROCHLORIDE	verapamil hydrochloride	TABLET;ORAL	071424-001	May 25, 1988		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Chartwell Rx

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Chartwell Rx	MOBAN	molindone hydrochloride	TABLET;ORAL	017111-008	Approved Prior to Jan 1, 1982	3,491,093	⤷ Try a Trial
Chartwell Rx	MOBAN	molindone hydrochloride	TABLET;ORAL	017111-004	Approved Prior to Jan 1, 1982	3,491,093	⤷ Try a Trial
Chartwell Rx	LIMBITROL	amitriptyline hydrochloride; chlordiazepoxide	TABLET;ORAL	016949-001	Approved Prior to Jan 1, 1982	4,316,897	⤷ Try a Trial
Chartwell Rx	MOBAN	molindone hydrochloride	TABLET;ORAL	017111-007	Approved Prior to Jan 1, 1982	3,491,093	⤷ Try a Trial
Chartwell Rx	MOBAN	molindone hydrochloride	TABLET;ORAL	017111-005	Approved Prior to Jan 1, 1982	3,491,093	⤷ Try a Trial
Chartwell Rx	MOBAN	molindone hydrochloride	TABLET;ORAL	017111-006	Approved Prior to Jan 1, 1982	3,491,093	⤷ Try a Trial
Chartwell Rx	LIMBITROL DS	amitriptyline hydrochloride; chlordiazepoxide	TABLET;ORAL	016949-002	Approved Prior to Jan 1, 1982	4,316,897	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.